Age at HPV vaccine initiation and completion among US adolescent girls: Trend from 2008 to 2012

Rahman, Mahbubur; McGrath, Christine J.; Hirth, Jacqueline M.; Berenson, Abbey B.

doi:10.1016/j.vaccine.2014.12.021

Cited by 29 publications

(21 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(Reagan-Steiner et al, 2016) In a national immunization survey of U.S. adolescent girls under the age of 13, 14.1% initiated HPV vaccination in a 1-year period. (Rahman et al, 2015)…”

Section: Discussionmentioning

confidence: 99%

Association of physicians perceived barriers with human papillomavirus vaccination initiation

Farias

Savas²,

Fernández³

et al. 2017

Preventive Medicine

View full text Add to dashboard Cite

Physician recommendation is a strong predictor of vaccine uptake, however their perceived barriers may prevent vaccination. Therefore, we determined the association between physicians’ perceived barriers to HPV vaccination and vaccination initiation. We surveyed pediatricians in a large network of clinics in Houston, Texas to assess their perceived barriers to vaccinating adolescents. We combined survey data with electronic medical records to determine HPV vaccination initiation over a 12-month study period (July 2014 – June 2015). Patients were 11–18 year olds who had not begun the vaccination series, had a physician visit during the study period, and whose physician completed the survey. We conducted a multilevel model clustered by physician controlling for patient and physician demographics to calculate the association between physician-reported barriers and HPV vaccination initiation. Among 36,827 patients seen by 134 pediatricians, 18.6% initiated HPV vaccination. The relative risk of initiating HPV vaccination were lower for patients whose physician reported concerns about HPV vaccine safety (RR: 0.75, 95% CI: 0.58–0.97), efficacy (RR: 0.73, 95% CI: 0.54–0.99), and the financial burden of the vaccine on patients (RR: 0.72, 95% CI: 0.58–0.88). After controlling for patient and physician characteristics, physician concern about the financial burden on patients was significantly associated with lower relative risk of initiating HPV vaccination (RR: 0.76, 95% CI: 0.64–0.90). In this large study we observed that physician-reported barriers are associated with HPV vaccination initiation. Interventions should be implemented to educate physicians on vaccine safety, efficacy, and that there is no patient cost for CDC-recommended vaccines.

show abstract

“…(Reagan-Steiner et al, 2016) In a national immunization survey of U.S. adolescent girls under the age of 13, 14.1% initiated HPV vaccination in a 1-year period. (Rahman et al, 2015)…”

Section: Discussionmentioning

confidence: 99%

Association of physicians perceived barriers with human papillomavirus vaccination initiation

Farias

Savas²,

Fernández³

et al. 2017

Preventive Medicine

View full text Add to dashboard Cite

show abstract

“…8 A notable improvement in the mean of age of HPV vaccine completion was observed during 2008-2012 (from 14.7 years to 13.1 years). 21 Intervention programs to improve HPV vaccine series completion during early adolescence are warranted to ensure adequate protection against HPV-related diseases.…”

Section: Discussionmentioning

confidence: 99%

Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators

Rahman

Laz

McGrath

et al. 2015

Clin Pediatr (Phila)

Self Cite

View full text Add to dashboard Cite

OBJECTIVE To examine correlates of vaccine series completion among young adolescent US girls who initiated the human papillomavirus (HPV) vaccine. METHODS We analyzed National Immunization Survey-Teens 2012 provider-verified data to examine correlates of HPV vaccine completion among 13-17 year old girls who initiated HPV vaccine in 2012 (N=4,548). RESULTS The weighted vaccine series completion rate among 13-17 year old girl initiators was 66.7% (95% confidence interval (CI), 64.0-69.3). Adolescent girls who were older, residents of the Northeast (adjusted prevalence ratio (aPR) 1.36, 95% CI 1.07-1.73), and had provider-verified seasonal influenza vaccination in the past year (aPR 1.67, 95% CI 1.32-2.11) and provider recommendation (aPR 1.40, 95% CI 1.10-1.77) were more likely to complete the 3-dose vaccine series. CONCLUSIONS Parents of younger adolescent girls need to be educated about the importance of completing the 3-dose HPV vaccine series. Provider recommendation for the vaccine would also facilitate series completion.

show abstract

“…Evidence indicates that vaccine coverage is low in women of lower socioeconomic status (SES) (27), older age (27, 28), lower education (22), and women of racial/ethnic minority status (29). Recent research suggests that women with higher BMI in a low-income population have lower uptake of HPV vaccine (30).…”

Section: Introductionmentioning

confidence: 99%

HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009–2014

Sundaram

Mason

Basta

2016

Vaccine

View full text Add to dashboard Cite

Background Human papillomavirus (HPV) vaccine uptake in the US is suboptimal; identifying risk factors associated with low vaccine uptake is critical to increase vaccination coverage. Some evidence suggests body mass index (BMI) is associated with low HPV vaccine uptake and increased risk of HPV infection in adults. BMI may therefore be an important factor in targeting HPV vaccine to US adolescents. Methods We investigated the relationship between BMI categories (underweight, normal weight, overweight and obese) and HPV vaccine uptake in 4109 adolescents (9–18 years old) using data from the 2009 to 2014 National Health and Nutrition Examination Survey (NHANES). We used modified Poisson regression to assess the relationship between BMI and receipt of at least one HPV vaccine, and BMI and completion of the vaccine three-dose series. We assessed the relationship between BMI and age at first HPV vaccination using linear regression. Results Receipt of at least one dose of HPV vaccine was low in both females (35%) and males (10%). High BMI was not associated with initiation of the HPV vaccine series, age at first HPV vaccination, or completion of the HPV vaccine three-dose course. Conclusions We found no evidence that high BMI is associated with reduced initiation or completion of the HPV vaccination series, or age at initiation of the three-dose course among a general population sample of US adolescents. Our results suggest that efforts to increase HPV vaccine uptake need not consider targeting by weight status at this time.

show abstract

Age at HPV vaccine initiation and completion among US adolescent girls: Trend from 2008 to 2012

Cited by 29 publications

References 10 publications

Association of physicians perceived barriers with human papillomavirus vaccination initiation

Association of physicians perceived barriers with human papillomavirus vaccination initiation

Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators

HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009–2014

Contact Info

Product

Resources

About